The pharmaceutical industry of the world: investment in R & D in the postcovid period
https://doi.org/10.21686/2410-7395-2022-3-62-70
Abstract
In the article, the authors analyzed the activities of pharmaceutical companies in the world in the field of research and development (R & D) on the basis of international and Russian statistics. The financing of R & D in pharmaceuticals traditionally retains its decisive role in the development of both the industry as a whole and the global economy and the social sphere in the conditions of the outpacing growth of the age qualification of the world's population, which is the relevance of the article. The purpose of the article is to identify new trends in the development of investment and R&D in the pharmaceutical industry. The authors conducted quantitative and qualitative monitoring of the parameters of pharmaceutical companies' activities in the field of research and development in the last decade and identified a number of fundamentally new trends, such as the emergence of new pharmaceutical technologies, evaluation of healthcare technologies by society/the state, digitalization (including digital interaction with customers whose base is becoming more diversified), price growth on drugs and research risks, transformation of the industry's business strategies and more flexible project management due to the impact of COVID-19, including in the field of research, development and investment in the pharmaceutical industry.
About the Authors
Szabolcs Nagy
Miskolc University
Hungary
Hungary
PhD, Dean the Institute of Economic Theory and Methodology, Faculty of Economics
Miskolc-Egyetemváros, 3515
R. R. Asmyatullin
Peoples' Friendship University of Russia
Russian Federation
Russian Federation
Ravil R. Asmyatullin, PhD, IMEB
6 Miklukho-Maklaya Street, Moscow, 117198
References
1. Asmyatullin R. R., Aydrus I. A., Sabolch N. Torgovye otnosheniya Vengrii i Rossii v ramkakh razvitiya farmatsevticheskoy promyshlennosti [International Trade between Hungary and Russia within the Development of the Pharmaceutical Industry]. Mezhdunarodnaya torgovlya i torgovaya politika [International Trade and Trade Policy], 2021, No. 7 (4), pp. 79–92. (In Russ.). DOI: 10.21686/2410-7395-2021-3-79-92
2. Budushchee Bolshoy Farmy: razvitie mirovoy farmatsevtiche-skoy industrii do 2022 g. [The Future of Big Pharma: the Development of the Global Pharmaceutical Industry until 2022]. (In Russ.). Available at: http://pharmapractice.ru/130976
3. Glavina S. G., Aydrus I. A. Z. Privlechenie kapitala biotekhnologicheskimi i farmatsevticheskimi kompaniyami: osobennosti evropey-skogo rynka [Capital Raising by Biotechnological and Pharmaceutical Companies: Features of the European Market]. Nauchnoe obozrenie. Seriya 1: Ekonomika i pravo [Scientific Review. Series 1: Economics and Law], 2021, No. 6, pp. 47–58. (In Russ.).
4. Srednie zatraty na issledovaniya i razrabotki dlya farmatsevticheskikh kompaniy [Average Research and Development Costs for Pharmaceutical Companies] (In Russ.). Available at: https://nesrakonk.ru/how-much-drug-companys-spending-allocated-research-and-development-average/
5. Summarnye globalnye raskhody na farmatsevticheskie issledovaniya i razrabotki s 2010 po 2024 god. [Total Global Expenditures on Pharmaceutical Research and Development from 2010 to 2024. (In Russ.). Available at: https://www.gluvexlab.com/articles/summarnye-globalnye-raschody-nafarmacevticheskie-issledovaniya-i-razrabotki-s-2010-po-2024-god/
6. Frolova E. D., Abdurakhmanova Z. A., Ishukov A. A. Osobennosti uchastiya farmatsevticheskikh predpriyatiy Kazakhstana v globalnykh tsepochkakh stoimosti [Features of Participation of Pharmaceutical Enterprises of Kazakhstan in Global Value Chains]. Ekonomika regiona [The Economy of the Region], 2021, Vol. 17, No. 2, pp. 473–485. (In Russ.). DOI: 10.17059/ekon.reg.2021-2-9
7. DiMasi J. A., Hansen R. W., Grabowski H. The Price of Innovation: New Estimates of Drug Development Costs. Journal of Health Economics, 2003, Vol. 22, pp. 151–185.
8. Global Trends in R & D: Overview through 2021. Available at: https://www.iqvia.com/insights/the-iqvia-institute/reports/global-trends-in-r-and-d-2022
9. Pharma R & D. Annual Review 2022: Navigating the Landscape. Available at: https://pages.pharmaintelligence.informa.com/rdreview
10. Taylor D. The Pharmaceutical Industry and the Future of Drug Development. Environmental Science and Technology, 2016, No. 41. DOI: 10.1039/9781782622345-00001
Review
For citations:
Nagy S., Asmyatullin R.R. The pharmaceutical industry of the world: investment in R & D in the postcovid period. International Trade and Trade Policy. 2022;8(4):62-70. (In Russ.) https://doi.org/10.21686/2410-7395-2022-3-62-70
Views:
637
Email this article 
